Yes, but P2b didn’t fail and now they have nearly
finished a number of P3 trials with likely DMOAD
action. No good hiding our heads in the sand.
As I intimated earlier, if trial results are good, lets
hope FDA are as pedantic with Bio Splice as
they have been with PAR.
Yes, but P2b didn’t fail and now they have nearlyfinished a...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.010(4.17%) |
Mkt cap ! $80.48M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 22.5¢ | $167.1K | 714.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 120730 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 49999 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |